Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Lisco

Showing results (1-10 of 81) with videos related to

Pageof 9
Sort By:
Endocrine, Metabolic & Immune Disorders Drug Targets|February 27, 2023
Right Ventricular Dysfunction and Exercise Impairment in Patients with Heart Failure, Insulin Resistance, and Diabetes Mellitus: Insights from the T.O.S.CA. Registry (Cardiovascular Diabetology 2022)Domenico Triggiani, Giuseppe Lisco
Journal of Diabetes|July 9, 2023
Computerized nailfold video-capillaroscopy in type 2 diabetes: A cross-sectional study on 102 outpatientsGiuseppe Lisco, Vincenzo Triggiani
Endocrine, Metabolic & Immune Disorders Drug Targets|December 16, 2021
Commentary on the Article "Multiple Hormonal and Metabolic Deficiency Syndrome Predicts Outcome in Heart Failure: The T.O.S.CA. Registry", Antonio Cittadini <i>et al</i>. Eur. J. Prev. Cardiol. 2021Vincenzo Triggiani, Giuseppe Lisco
Frontiers in Endocrinology|December 2, 2022
Effect of levothyroxine replacement therapy in patients with subclinical hypothyroidism and chronic heart failure: A systematic reviewVincenzo Triggiani, Antonio Cittadini, Giuseppe Lisco
Journal of Cardiovascular Development and Disease|April 27, 2026
Obesity and Heart Failure: Introducing the ThemeFrancesco Monitillo, Paolo Basile, Giuseppe Lisco
Endocrine, Metabolic & Immune Disorders Drug Targets|March 19, 2025
Ultra-Processed Food Consumption during the COVID-19 PandemicDomenico Triggiani, Vincenzo Triggiani, Giuseppe Lisco
Frontiers in Endocrinology|January 21, 2025
Editorial: Metabolic disorders as risk factors for osteoarthritis and targeted therapies for this pathologyGiuseppe Lisco, Hee Geun Jo, Graziana Colaianni
Endocrine, Metabolic & Immune Disorders Drug Targets|July 7, 2020
Fixed-Ratio Combinations of Basal Insulin and GLP-1RA in the Management of Type 2 Diabetes Mellitus: Highlights from the LiteratureGiuseppe Lisco, Anna De Tullio, Edoardo Guastamacchia, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|November 20, 2019
Congestive Heart Failure and Thyroid Dysfunction: The Role of the Low T3 Syndrome and Therapeutic AspectsGiuseppe Lisco, Anna De Tullio, Massimo Iacoviello, et al.
Andrology|June 28, 2020
Critical evaluation of different available guidelines for late-onset hypogonadismVito Angelo Giagulli, Marco Castellana, Giuseppe Lisco, et al.
Pageof 9

Showing results (1-10 of 81) with videos related to

Sort By:
Pageof 9
Endocrine, Metabolic & Immune Disorders Drug Targets|February 27, 2023
Right Ventricular Dysfunction and Exercise Impairment in Patients with Heart Failure, Insulin Resistance, and Diabetes Mellitus: Insights from the T.O.S.CA. Registry (Cardiovascular Diabetology 2022)Domenico Triggiani, Giuseppe Lisco
Journal of Diabetes|July 9, 2023
Computerized nailfold video-capillaroscopy in type 2 diabetes: A cross-sectional study on 102 outpatientsGiuseppe Lisco, Vincenzo Triggiani
Endocrine, Metabolic & Immune Disorders Drug Targets|December 16, 2021
Commentary on the Article "Multiple Hormonal and Metabolic Deficiency Syndrome Predicts Outcome in Heart Failure: The T.O.S.CA. Registry", Antonio Cittadini <i>et al</i>. Eur. J. Prev. Cardiol. 2021Vincenzo Triggiani, Giuseppe Lisco
Frontiers in Endocrinology|December 2, 2022
Effect of levothyroxine replacement therapy in patients with subclinical hypothyroidism and chronic heart failure: A systematic reviewVincenzo Triggiani, Antonio Cittadini, Giuseppe Lisco
Journal of Cardiovascular Development and Disease|April 27, 2026
Obesity and Heart Failure: Introducing the ThemeFrancesco Monitillo, Paolo Basile, Giuseppe Lisco
Endocrine, Metabolic & Immune Disorders Drug Targets|March 19, 2025
Ultra-Processed Food Consumption during the COVID-19 PandemicDomenico Triggiani, Vincenzo Triggiani, Giuseppe Lisco
Frontiers in Endocrinology|January 21, 2025
Editorial: Metabolic disorders as risk factors for osteoarthritis and targeted therapies for this pathologyGiuseppe Lisco, Hee Geun Jo, Graziana Colaianni
Endocrine, Metabolic & Immune Disorders Drug Targets|July 7, 2020
Fixed-Ratio Combinations of Basal Insulin and GLP-1RA in the Management of Type 2 Diabetes Mellitus: Highlights from the LiteratureGiuseppe Lisco, Anna De Tullio, Edoardo Guastamacchia, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|November 20, 2019
Congestive Heart Failure and Thyroid Dysfunction: The Role of the Low T3 Syndrome and Therapeutic AspectsGiuseppe Lisco, Anna De Tullio, Massimo Iacoviello, et al.
Andrology|June 28, 2020
Critical evaluation of different available guidelines for late-onset hypogonadismVito Angelo Giagulli, Marco Castellana, Giuseppe Lisco, et al.
Pageof 9